Close Menu

NEW YORK — VolitionRx said on Wednesday that it has priced its planned $20 million public offering of 3.8 million shares.

The Austin, Texas-based company also said that it has granted Cantor Fitzgerald, which is underwriting the offering, a 30-day option to purchase up to 571,428 additional shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.